目前批准的免疫检查点抑制剂的阿基里斯:与免疫相关的不良事件
Ting Yan1, Lun Yu2, Jiwen Zhang1,3
1Department of Pharmacy, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Frontiers in immunology
|February 27, 2024
概括
免疫检查点抑制剂 (ICI) 提供了新的癌症治疗方法,但可以引起与免疫相关的不良事件 (irAEs). 本综述详细介绍了irAEs,用葡萄皮质类药物对其进行管理,以及需要多学科护理的情况.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫疗法,特别是免疫检查点抑制剂 (ICI),已经改变了癌症治疗.
- 增加ICI的使用导致免疫相关不良事件 (irAEs) 的增加.
- 了解irrAEs对于管理接受免疫治疗的患者至关重要.
研究的目的:
- 综合审查irAEs的病原性.
- 详细介绍各种IRE的临床表现,发病率和治疗策略.
- 突出警监测和多学科管理的重要性.
主要方法:
- 关于irAEs的发病,临床表现和治疗的文献综述.
- 分析与ICI相关的常见和罕见毒性.
- 检查管理策略,包括使用葡萄糖皮质激素和停止ICI.
主要成果:
- irAEs是由直接抗体效应和T细胞介导的免疫反应引起的.
- 常见的IRE影响皮肤,内分泌系统,胃肠道和肝脏.
- 罕见但可能致命的irrAEs包括神经毒性,心脏毒性和肺毒性.
结论:
- 有效管理irAEs需要及时识别和干预,通常是用葡萄糖皮质激素.
- 严重的IRE可能需要暂时或永久停止ICI.
- 多学科的方法对于最佳的患者护理和结果至关重要.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cytotoxic T Cells-mediated Immune Response
910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910
Immunodeficiency Diseases
939
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
939
Cell-mediated Immune Responses
68.3K
Overview
68.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K


